Xiaoli Xu

机构：Zhejiang Medicine (China), Chongqing Medical University · ORCID：0000-0003-0920-4811

发表论文 44 篇 · 总被引 1310 次 · h-index 16

代表论文

• A CRISPR–Cas9-based gene drive platform for genetic interaction analysis in Candida albicans (2017 · Nature Microbiology · 被引 182)
• Antibody neutralization of microbiota-derived circulating peptidoglycan dampens inflammation and ameliorates autoimmunity (2019 · Nature Microbiology · 被引 109)
• A peptidoglycan storm caused by β-lactam antibiotic’s action on host microbiota drives Candida albicans infection (2021 · Nature Communications · 被引 95)
• LncRNA DINOR is a virulence factor and global regulator of stress responses in Candida auris (2021 · Nature Microbiology · 被引 76)
• BCG‐Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations (2020 · Journal of Immunology Research · 被引 43)
• MIG1 Regulates Resistance of Candida albicans against the Fungistatic Effect of Weak Organic Acids (2015 · Eukaryotic Cell · 被引 34)